Vitamin D Treatment in Ulcerative Colitis
| Status: | Completed |
|---|---|
| Conditions: | Colitis, Irritable Bowel Syndrome (IBS), Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/7/2015 |
| Start Date: | July 2012 |
| End Date: | December 2014 |
| Contact: | Joel Pekow, M.D. |
| Email: | jpekow@medicine.bsd.uchicago.edu |
| Phone: | 773-834-8632 |
The purpose of this study is to test blood and tissue samples of people with Ulcerative
Colitis (UC) to see what effects Vitamin D3 may have on the immune system. This research is
being done because it could lead to the development of new treatment for people with
Inflammatory Bowel Disease (IBD).
Colitis (UC) to see what effects Vitamin D3 may have on the immune system. This research is
being done because it could lead to the development of new treatment for people with
Inflammatory Bowel Disease (IBD).
The primary endpoint of the trial is the change in colonic permeability as a global
assessment of vitamin D3 effects throughout the colon in patients with Ulcerative Colitis.
Secondary endpoints will be changes in colonic tight junction protein expression, and their
relationship to serum vitamin D level, VDR expression, inflammatory cytokines, and
histologic inflammation
assessment of vitamin D3 effects throughout the colon in patients with Ulcerative Colitis.
Secondary endpoints will be changes in colonic tight junction protein expression, and their
relationship to serum vitamin D level, VDR expression, inflammatory cytokines, and
histologic inflammation
Inclusion Criteria:
- Patients must be over 18 years of age
- have a diagnosis of UC as confirmed by histology.
- UC patients must have active but mild disease as confirmed by a Mayo Clinic endoscopy
score from 2-4,
- not requiring medication adjustment during the trial.
- Patients must be capable of understanding the purpose, risks and expectations of
study participation and willing to provide written informed consent.
Exclusion Criteria:
- Individuals on vitamin D or laxative therapy (except for purposes of endoscopy
preparation),
- UC patients with fulminant colitis or active C difficile or other colonic infections,
- age<18 year old,
- individuals with bleeding disorders will be excluded from the study.
We found this trial at
1
site
Click here to add this to my saved trials
